3654 results for «415»

Filter By

3654 results

Left main multivessel disease and other coronary interventions

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!

Left main multivessel disease and other coronary interventions

Mitral and other valvular and structural interventions

15 Dec 2022 – From GulfPCR-GIM 2022

Take advantage of this GulfPCR-GIM 2022 session to observe inadvertent pulmonary artery puncture during balloon valvuloplasty in a pregnant patient with severe rheumatic mitral stenosis, device sizing in transcatheter closure of a ruptured sinus of Valsalva aneurysm, and more!

Mitral and other valvular and structural interventions

Left main and multivessel disease - Session 1

15 Dec 2022 – From GulfPCR-GIM 2022

Consult this session on left main and multivessel disease to discover a selection of cases presented during Gulf PCR 2022: multiple bifurcation lesions in an octogenarian and high-bleeding risk case, left anterior descending CTO complicated by left main thrombus with left main trifurcation stenting, and much more!

Left main and multivessel disease - Session 1

STEMI - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

Among the 4 GulfPCR-GIM 2022 cases presented in this session, discover a curious case of type 4 dual left anterior descending artery presenting with STEMI, or an inferior wall STEMI with complete heart block in anomalous right coronary artery.

STEMI - Tools, devices and techniques

STEMI - Adjunctive pharmacotherapy

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will enable you to view a case of cardiogenic shock on anterior STEMI, as well as a complicated double-vessel intervention in inferior wall myocardial infarction with cardiogenic shock and acute LVF-PCI-RCA and LMCA-LAD, among others!

STEMI - Adjunctive pharmacotherapy

Left main and multivessel disease - Session 2

15 Dec 2022 – From GulfPCR-GIM 2022

View a sudden LM stem occlusion, a LM dissection during CTO, or even a rotablation in LM triple vessel disease in severe left ventricle dysfunction, and much more in this GulfPCR-GIM 2022 session.

Left main and multivessel disease - Session 2

The why and how of performing plaque modification in calcified lesions

15 Dec 2022 – From GulfPCR-GIM 2022

Consult this session to learn more about the different kinds of lesions we face during coronary angiography and the different tools and techniques available to treat calcified lesions, as well as to discover how to prepare for each procedure to treat calcified lesion and how to manage complications.

The why and how of performing plaque modification in calcified lesions

Bifurcation lesion - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!

Bifurcation lesion - Tools, devices and techniques

CTO - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn how a left anterior descending in-stent CTO was rescued by epicardial retrograde wiring, how a guidewire was redirected using a dual lumen microcath, how a CTO intervention was treated in an anomalous right coronary artery, and more!

CTO - Tools, devices and techniques

Artificially synthesized optical coherence tomography images based on intravascular ultrasound-virtual histology examination of diseased coronary artery

05 May 2021

Intravascular imaging is a cornerstone of invasive management of coronary disease, requiring specialized training to interpret either IVUS or OCT. AI can facilitate interpretation by non-specialists in real time.

AI-generated synthetic OCT

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan
Ali Nazmi Calik

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?